Mikala Egeblad

Summary

Affiliation: University of South Florida
Country: USA

Publications

  1. pmc Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development
    Mikala Egeblad
    Department of Anatomy, University of California, San Francisco, San Francisco, California 94143 0452, USA
    Dev Dyn 236:1683-93. 2007
  2. pmc Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells
    John J Engelhardt
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
    Cancer Cell 21:402-17. 2012
  3. pmc Stromal regulation of vessel stability by MMP14 and TGFbeta
    Nor E Sounni
    Cancer Research Institute, University of California San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA
    Dis Model Mech 3:317-32. 2010
  4. pmc Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells
    Yi Li
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Proc Natl Acad Sci U S A 100:15853-8. 2003

Collaborators

  • Zena Werb
  • Lisa M Coussens
  • Farrah Kheradmand
  • Katrina Podsypanina
  • Leon van Kempen
  • John J Engelhardt
  • Nor E Sounni
  • Yi Li
  • Caitlin Sorensen
  • Peter Beemiller
  • Bijan Boldajipour
  • Matthew F Krummel
  • Priya Pandurangi
  • Jennifer Shen
  • Kerstin Dehne
  • Nancy Boudreau
  • Simon Junankar
  • Charlotte J Morrison
  • Nesrine I Affara
  • Lidiya Korets
  • Stephen M Krane
  • Jane Wiesen
  • Jake Lee
  • Ileana Cuevas
  • Christopher M Overall
  • Pam Cowin
  • Jeffrey M Rosen
  • Shixia Huang
  • Bryan Welm
  • Mario Chamorro
  • Lee K Tan
  • Xiaomei Zhang
  • Harold E Varmus
  • Tracey Rowlands

Detail Information

Publications4

  1. pmc Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development
    Mikala Egeblad
    Department of Anatomy, University of California, San Francisco, San Francisco, California 94143 0452, USA
    Dev Dyn 236:1683-93. 2007
    ..Developmental Dynamics 236:1683-1693, 2007. (c) 2007 Wiley-Liss, Inc...
  2. pmc Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells
    John J Engelhardt
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
    Cancer Cell 21:402-17. 2012
    ..The spatiotemporal dynamics revealed here implicate nonproductive interactions between T cells and antigen-presenting cells on the tumor margin...
  3. pmc Stromal regulation of vessel stability by MMP14 and TGFbeta
    Nor E Sounni
    Cancer Research Institute, University of California San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA
    Dis Model Mech 3:317-32. 2010
    ..Antagonists of this pathway could be therapeutically exploited to improve the delivery of therapeutics or molecular contrast agents into tissues where chronic damage or neoplastic disease limits their efficient delivery...
  4. pmc Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells
    Yi Li
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Proc Natl Acad Sci U S A 100:15853-8. 2003
    ..Thus, the developmental heterogeneity of different breast cancers is in part a consequence of differential effects of oncogenes on distinct cell types in the breast...